You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Colorcon
Moodys
McKinsey
Dow

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Patent: 5,968,825

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,968,825
Title: Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene
Abstract:The following description sets forth antisense (AS) oligonucleotides (ODNs) complementary to the primary transcript of the human c-fes protooncogene and their use to inactivate said transcript. All-trans retinoic acid (ATRA) is reported to be used as a differentiation inducer on cells pretreated with said AS-ODNs to induce apoptosis of leukemic blast cells.
Inventor(s): Ferrari; Sergio (Modena, IT), Manfredini; Rossella (Campogalliano, IT)
Assignee: Istituto Biochimico Italiano Giovanni Lorenzini S.P.A. (Milan, IT)
Application Number:08/859,389
Patent Claims:see list of patent claims

Details for Patent 5,968,825

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Istituto Biochimico Italiano Giovanni Lorenzini S.P.A. (Milan, IT) 2016-05-20 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Istituto Biochimico Italiano Giovanni Lorenzini S.P.A. (Milan, IT) 2016-05-20 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Istituto Biochimico Italiano Giovanni Lorenzini S.P.A. (Milan, IT) 2016-05-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Dow
Moodys
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.